Report #2897229

Received May 20, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: IL
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (3)

ErythemaMalaisePyrexia

Symptom narrative

became ill; chest was red raw; fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of unwell in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, immediately after receiving Shingrix, the patient experienced unwell (Verbatim: became ill), localized erythema (Verbatim: chest was red raw) and fever (Verbatim: fever). The outcome of the unwell, localized erythema and fever were unknown. It was unknown if the reporter considered the unwell, localized erythema and fever to be related to Shingrix. It was unknown if the company considered the unwell, localized erythema and fever to be related to Shingrix. Additional Information: GSK Receipt Date: 13-MAY-2026 The batch number was not provided upon follow- up with the reporter.